These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20482803)

  • 1. Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide.
    Lemos CN; Reis FM; Pena GN; Silveira LC; Camargos AF
    Reprod Biol Endocrinol; 2010 May; 8():51. PubMed ID: 20482803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
    Li X; Kang X; Deng Q; Cai J; Wang Z
    Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?
    Parlakgumus HA; Kilicdag EB; Bolat FA; Haydardedeoglu B; Parlakgumus A
    Arch Gynecol Obstet; 2015 Jun; 291(6):1403-10. PubMed ID: 25472738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats.
    Tsuyoshi H; Orisaka M; Fukuda S; Hattori K; Tsang BK; Yoshida Y
    Steroids; 2015 Jan; 93():1-7. PubMed ID: 25449767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.
    Knudtson JF; Tellez Santos M; Failor CM; Binkley PA; Venesky JP; Tekmal RR; Robinson RD; Schenken RS
    Reprod Sci; 2017 Sep; 24(9):1280-1283. PubMed ID: 28290768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females.
    Potolog-Nahari C; Fishman A; Cohen I
    Gynecol Endocrinol; 2007 May; 23(5):290-4. PubMed ID: 17558688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthotopic transplantation of cryopreserved mouse ovaries and gonadotrophin releasing hormone analogues in the restoration of function following chemotherapy-induced ovarian damage.
    Li Q; Szatmary P; Liu Y; Ding Z; Zhou J; Sun Y; Luo F; Wang Y; Zhu J
    PLoS One; 2015; 10(3):e0120736. PubMed ID: 25811681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
    Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
    Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian function reconstruction by orthotopic transplantation of novel vitrification cryopreserved ovaries in chemotherapy-induced ovary damage rat model].
    Li Q; Chen Y; Yang L; Sun Y; Wang Y; Zhu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1116-21. PubMed ID: 24279027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.
    Meirow D; Assad G; Dor J; Rabinovici J
    Hum Reprod; 2004 Jun; 19(6):1294-9. PubMed ID: 15117898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to assess the use of the gonadotrophin antagonist cetrorelix in preserving ovarian function during chemotherapy.
    Whitehead J; Toledo MG; Stern CJ
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):452-4. PubMed ID: 21810087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hGHRH homodimer promotes fertility of female infertile hamster by up-regulating ovarian GHRH receptor without triggering GH secretion.
    Zhang JH; Zhang XD; Yue LN; Guo XY; Tang JX; Guo LR; Li Y; Tang SS
    Eur J Pharm Sci; 2018 May; 117():341-350. PubMed ID: 29526766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
    Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
    Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.
    Chen H; Xiao L; Li J; Cui L; Huang W
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
    Xing W; Lin H; Li Y; Yang D; Wang W; Zhang Q
    PLoS One; 2015; 10(10):e0140286. PubMed ID: 26468951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.